- Home
- WOW vs IMMP Comparison
WOW vs IMMP Comparison
Compare WOW & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOW
- IMMP
- Stock Information
- Founded
- WOW 2001
- IMMP 1987
- Country
- WOW United States
- IMMP Australia
- Employees
- WOW N/A
- IMMP N/A
- Industry
- WOW Cable & Other Pay Television Services
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- WOW Telecommunications
- IMMP Health Care
- Exchange
- WOW Nasdaq
- IMMP Nasdaq
- Market Cap
- WOW 356.9M
- IMMP 304.0M
- IPO Year
- WOW 2017
- IMMP N/A
- Fundamental
- Price
- WOW $4.80
- IMMP $1.92
- Analyst Decision
- WOW Buy
- IMMP Buy
- Analyst Count
- WOW 2
- IMMP 2
- Target Price
- WOW $7.50
- IMMP $8.50
- AVG Volume (30 Days)
- WOW 269.8K
- IMMP 72.2K
- Earning Date
- WOW 03-12-2025
- IMMP 03-03-2025
- Dividend Yield
- WOW N/A
- IMMP N/A
- EPS Growth
- WOW N/A
- IMMP N/A
- EPS
- WOW N/A
- IMMP N/A
- Revenue
- WOW $647,100,000.00
- IMMP $2,563,302.00
- Revenue This Year
- WOW N/A
- IMMP N/A
- Revenue Next Year
- WOW N/A
- IMMP $47.79
- P/E Ratio
- WOW N/A
- IMMP N/A
- Revenue Growth
- WOW N/A
- IMMP 9.59
- 52 Week Low
- WOW $2.31
- IMMP $1.66
- 52 Week High
- WOW $5.80
- IMMP $3.34
- Technical
- Relative Strength Index (RSI)
- WOW 59.73
- IMMP 43.56
- Support Level
- WOW $4.33
- IMMP $1.94
- Resistance Level
- WOW $5.00
- IMMP $2.08
- Average True Range (ATR)
- WOW 0.18
- IMMP 0.08
- MACD
- WOW 0.08
- IMMP -0.00
- Stochastic Oscillator
- WOW 75.88
- IMMP 20.00
About WOW WideOpenWest Inc.
WideOpenWest Inc is a cable operator and broadband service, provider. The company serves residential, business and wholesale customers in Illinois, Michigan, Indiana, Ohio, Kansas, Tennessee, Maryland, and South Carolina. Its service portfolio consists of high-speed internet, data, voice, cloud, and cable television services. The company operates in one business segment that is Broadband Services. The majority of the revenue is generated from the subscription service revenue received.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.